Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection.

After rising over a 35-year period, thyroid cancer incidence in the U.S. plateaued from 2010 to 2019, according to findings published in The Lancet Diabetes & Endocrinology. In a retrospective ...

A session on thyroid cancer had updates on the risk of thyroid cancer with GLP-1 RA use; malignancy in Bethesda III, IV nodules; and treatment of RET-Mutated Medullary and TRK-Fusion Thyroid Cancer.

The thyroid cancer patients who responded to the survey accounted for both men and women, ages 13 to 80. More than half were younger than 40, which is unusual in itself. The average age when a ...

Of those with thyroid cancer, 430 with hypoparathyroidism (median age, 55 years; 89.1% women) and 850 without hypoparathyroidism (median age, 55 years; 80% women) were included in the study.

Thyroid cancer cells can potentially spread to the lymph nodes in the neck and chest areas. The stages for this category depend on if the cancer has spread to the lymph nodes, as well as which ...

The data showed the annual incidence of thyroid cancer in the United States increased from 5.0 cases per 100,000 people in 1975 to 14.6 cases per 100,000 people in 2009.